Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Trefzer

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Springer Seminars in Immunopathology|January 1, 1992
Modulation of the expression of intercellular adhesion molecule-1 (ICAM-1) in human keratinocytes by ultraviolet (UV) radiationJ Krutmann, U Trefzer
Advances in Experimental Medicine and Biology|February 23, 1999
Hybrid cell vaccination in cancer immunotherapy. Recruitment and activation of T cell help for induction of anti tumour cytotoxic T cellsG Stuhler, U Trefzer, P Walden
Clinical and Experimental Dermatology|May 27, 2010
Ultra-late recurrence of malignant melanoma after a disease-free interval of 41 yearsD Terhorst, C Radke, U Trefzer
Deutsche Medizinische Wochenschrift (1946)|August 23, 2003
[Cutaneous side effects of clinically relevant cytokine therapies]U Trefzer, M Hofmann, W Sterry
Clinical and Experimental Dermatology|December 5, 2002
Cytokines: interleukin and interferon therapy in dermatologyK Asadullah, W Sterry, U Trefzer
Experimental Dermatology|May 8, 2002
Cytokine therapy in dermatologyK Asadullah, W Sterry, U Trefzer
Clinical and Experimental Dermatology|August 12, 2009
Hypertrichosis in three patients treated with interferon-alpha2F Kiecker, M A Hofmann, U Trefzer
Ernst Schering Research Foundation Workshop|August 16, 2000
The hybrid cell vaccination approach to cancer immunotherapyU Trefzer, G Herberth, W Sterry, et al.
Methods in Molecular Medicine|March 11, 2011
Hybrid cell vaccination in patients with metastatic melanomaU Trefzer, G Weingart, W Sterry, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 22, 2006
Vitiligo-like depigmentation as a presenting sign of metastatic melanomaF Kiecker, M Hofmann, W Sterry, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Springer Seminars in Immunopathology|January 1, 1992
Modulation of the expression of intercellular adhesion molecule-1 (ICAM-1) in human keratinocytes by ultraviolet (UV) radiationJ Krutmann, U Trefzer
Advances in Experimental Medicine and Biology|February 23, 1999
Hybrid cell vaccination in cancer immunotherapy. Recruitment and activation of T cell help for induction of anti tumour cytotoxic T cellsG Stuhler, U Trefzer, P Walden
Clinical and Experimental Dermatology|May 27, 2010
Ultra-late recurrence of malignant melanoma after a disease-free interval of 41 yearsD Terhorst, C Radke, U Trefzer
Deutsche Medizinische Wochenschrift (1946)|August 23, 2003
[Cutaneous side effects of clinically relevant cytokine therapies]U Trefzer, M Hofmann, W Sterry
Clinical and Experimental Dermatology|December 5, 2002
Cytokines: interleukin and interferon therapy in dermatologyK Asadullah, W Sterry, U Trefzer
Experimental Dermatology|May 8, 2002
Cytokine therapy in dermatologyK Asadullah, W Sterry, U Trefzer
Clinical and Experimental Dermatology|August 12, 2009
Hypertrichosis in three patients treated with interferon-alpha2F Kiecker, M A Hofmann, U Trefzer
Ernst Schering Research Foundation Workshop|August 16, 2000
The hybrid cell vaccination approach to cancer immunotherapyU Trefzer, G Herberth, W Sterry, et al.
Methods in Molecular Medicine|March 11, 2011
Hybrid cell vaccination in patients with metastatic melanomaU Trefzer, G Weingart, W Sterry, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 22, 2006
Vitiligo-like depigmentation as a presenting sign of metastatic melanomaF Kiecker, M Hofmann, W Sterry, et al.
Pageof 5